By SourceProkaryotic Exonucleases · Eukaryotic Exonucleases · Viral Exonucleases · and Recombinant/Synthetic Exonucleases
By Product FormatReagents and Kits and Instruments and Systems
By Reaction SpecificityDNA-Specific Exonucleases · RNA-Specific Exonucleases · and DNase/RNase Dual-Specific Exonucleases
By ApplicationPCR Cleanup · DNA Sequencing Workflows · RNA Sequencing Workflows · Cloning and Molecular Cloning Workflows · Genome Editing Protocols · DNA Repair and Mismatch Repair Studies · Protein–Nucleic Acid Interaction Studies · Diagnostic Assays · and Biopharmaceutical R and D Workflows
By End UserAcademic and Research Institutes · Biotechnology Companies · Pharmaceutical Companies · Clinical and Diagnostic Laboratories · and Contract Research Organizations
By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
Published In01 Apr 2026
Report CodeCMI9057
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
Product Type Insights (Revenue, USD Mn, 2021 - 2033)
Single-stranded exonucleases
Double-stranded exonucleases
Enzyme Type Insights (Revenue, USD Mn, 2021 - 2033)
5 3 Exonucleases
3 5 Exonucleases
Dual-Activity Exonucleases
Proofreading Exonucleases
Mismatch Repair Exonucleases
Restriction-Associated Exonucleases
Source Insights (Revenue, USD Mn, 2021 - 2033)
Prokaryotic Exonucleases
Eukaryotic Exonucleases
Viral Exonucleases
Recombinant/Synthetic Exonucleases
Product Format Insights (Revenue, USD Mn, 2021 - 2033)